NO20005497L - Heterocykliske derivater som inhiberer faktor Xa - Google Patents

Heterocykliske derivater som inhiberer faktor Xa

Info

Publication number
NO20005497L
NO20005497L NO20005497A NO20005497A NO20005497L NO 20005497 L NO20005497 L NO 20005497L NO 20005497 A NO20005497 A NO 20005497A NO 20005497 A NO20005497 A NO 20005497A NO 20005497 L NO20005497 L NO 20005497L
Authority
NO
Norway
Prior art keywords
heterocyclic derivatives
inhibit factor
relates
antithrombotic
anticoagulant
Prior art date
Application number
NO20005497A
Other languages
English (en)
Other versions
NO20005497D0 (no
NO320893B1 (no
Inventor
Peter William Rodney Caulkett
Roger James
Stuart Eric Pearson
Anthony Michael Slater
Rolf Peter Walker
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9809351.1A external-priority patent/GB9809351D0/en
Priority claimed from GBGB9903337.5A external-priority patent/GB9903337D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005497D0 publication Critical patent/NO20005497D0/no
Publication of NO20005497L publication Critical patent/NO20005497L/no
Publication of NO320893B1 publication Critical patent/NO320893B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20005497A 1998-05-02 2000-11-01 Heterocykliske derivater som inhiberer faktor Xa og anvendelse derav, samt farmasoytisk sammensetning. NO320893B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9809351.1A GB9809351D0 (en) 1998-05-02 1998-05-02 Heterocyclic derivatives
GBGB9903337.5A GB9903337D0 (en) 1999-02-16 1999-02-16 Heterocyclic derivatives
PCT/GB1999/001308 WO1999057113A1 (en) 1998-05-02 1999-04-27 Heterocyclic derivatives which inhibit factor xa

Publications (3)

Publication Number Publication Date
NO20005497D0 NO20005497D0 (no) 2000-11-01
NO20005497L true NO20005497L (no) 2000-12-21
NO320893B1 NO320893B1 (no) 2006-02-06

Family

ID=26313572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005497A NO320893B1 (no) 1998-05-02 2000-11-01 Heterocykliske derivater som inhiberer faktor Xa og anvendelse derav, samt farmasoytisk sammensetning.

Country Status (22)

Country Link
US (2) US6753331B1 (no)
EP (2) EP1082321B1 (no)
JP (1) JP2002513790A (no)
KR (1) KR20010043246A (no)
CN (1) CN1133634C (no)
AT (1) ATE282610T1 (no)
AU (1) AU754453B2 (no)
BR (1) BR9910179A (no)
CA (1) CA2331042A1 (no)
DE (1) DE69921994T2 (no)
EE (1) EE200000527A (no)
ES (1) ES2232131T3 (no)
HU (1) HUP0101712A3 (no)
IL (1) IL139406A (no)
NO (1) NO320893B1 (no)
NZ (1) NZ507835A (no)
PL (1) PL343706A1 (no)
PT (1) PT1082321E (no)
SI (1) SI1082321T1 (no)
SK (1) SK16512000A3 (no)
TR (1) TR200003200T2 (no)
WO (1) WO1999057113A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
GB9914342D0 (en) * 1999-06-19 1999-08-18 Zeneca Ltd Compound
GB9917344D0 (en) * 1999-07-24 1999-09-22 Zeneca Ltd Novel salt
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
GB0012448D0 (en) 2000-05-24 2000-07-12 Astrazeneca Ab New process
MXPA03004112A (es) * 2000-11-09 2003-08-19 Astrazeneca Ab Composicion farmaceutica oral que contiene un copolimero de bloque.
GB0104752D0 (en) * 2001-02-27 2001-04-18 Astrazeneca Ab Pharmaceutical compositions
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
WO2005012293A1 (ja) * 2003-08-01 2005-02-10 Nippon Soda Co., Ltd. フェニルアゾール化合物、製造法および抗酸化薬
SE0400014D0 (sv) 2004-01-08 2004-01-08 Astrazeneca Ab Heterocyclic derivatives
WO2007008143A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
WO2007008144A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
US20080221063A1 (en) * 2005-07-08 2008-09-11 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa
WO2007008145A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
BR112020018094A2 (pt) 2018-03-08 2020-12-22 Incyte Corporation Compostos de aminopirazina diol como inibidores de pi3k-¿
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
RS66218B1 (sr) 2019-07-01 2024-12-31 Tonix Pharma Ltd Anti-cd154 antitela i njihove upotrebe
WO2022150452A1 (en) 2021-01-06 2022-07-14 Seth Lederman Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
WO1997023212A1 (en) * 1995-12-21 1997-07-03 The Du Pont Merck Pharmaceutical Company ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
GB9602294D0 (en) * 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
WO1998054164A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
GB9715894D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic derivatives
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate

Also Published As

Publication number Publication date
CN1308631A (zh) 2001-08-15
US6753331B1 (en) 2004-06-22
WO1999057113A1 (en) 1999-11-11
DE69921994T2 (de) 2005-12-01
IL139406A (en) 2004-07-25
JP2002513790A (ja) 2002-05-14
CN1133634C (zh) 2004-01-07
TR200003200T2 (tr) 2001-02-21
EP1082321B1 (en) 2004-11-17
CA2331042A1 (en) 1999-11-11
DE69921994D1 (de) 2004-12-23
HUP0101712A2 (hu) 2001-11-28
EP1528061A1 (en) 2005-05-04
HUP0101712A3 (en) 2003-01-28
PT1082321E (pt) 2005-03-31
SK16512000A3 (sk) 2001-05-10
HK1034711A1 (en) 2001-11-02
AU3620699A (en) 1999-11-23
SI1082321T1 (en) 2005-06-30
NO20005497D0 (no) 2000-11-01
ATE282610T1 (de) 2004-12-15
BR9910179A (pt) 2001-01-09
KR20010043246A (ko) 2001-05-25
EP1082321A1 (en) 2001-03-14
PL343706A1 (en) 2001-08-27
ES2232131T3 (es) 2005-05-16
EE200000527A (et) 2002-02-15
NZ507835A (en) 2003-01-31
AU754453B2 (en) 2002-11-14
IL139406A0 (en) 2001-11-25
NO320893B1 (no) 2006-02-06
US20040266759A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
DK1000033T3 (da) Heterocykliske derivater, som inhiberer Faktor Xa
NO20005497L (no) Heterocykliske derivater som inhiberer faktor Xa
MY124122A (en) Heterocyclic derivatives
TW200510297A (en) Substituted n-aryl heterocycles, process for their preparation and their use as medicaments
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
AU3620799A (en) Heterocyclic derivatives which inhibit factor xa
ATE267816T1 (de) Tan-1057 derivate
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
NO20013921D0 (no) Heterosykliske derivater som inhibitorer av faktor XA
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους